FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/06/069131 [Registered on: 18/06/2024] Trial Registered Prospectively
Last Modified On: 07/06/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug
Siddha 
Study Design  Single Arm Study 
Public Title of Study   A Study to evaluate the therapeutic effectiveness of selective Siddha Medicines – VeBSaM Therapy in the management of Cholelithiasis 
Scientific Title of Study   An Open clinical trial to evaluate the therapeutic effectiveness of selective Siddha Medicines - VeBSaM Therapy in the management of Cholelithiasis 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr NISHA K J 
Designation  PG Scholar 
Affiliation  National Institute of Siddha 
Address  Room no 7/8, Department of Maruthuvam, National Institute of Siddha, Tambaram Sanatorium

Chennai
TAMIL NADU
600047
India 
Phone  9965360794  
Fax    
Email  nishajageerushan@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr T LAKSHMIKANTHAM 
Designation  Associate Professor and Head of the Department (I/C) 
Affiliation  National Institute of Siddha 
Address  Room no 7/8, Department of Maruthuvam, National Institute of Siddha, Tambaram Sanatorium

Chennai
TAMIL NADU
600047
India 
Phone  9025575185  
Fax    
Email  drlakshmiramaswamy@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr T LAKSHMIKANTHAM 
Designation  Associate Professor and Head of the Department (I/C) 
Affiliation  National Institute of Siddha 
Address  Room no 7/8, Department of Maruthuvam, National Institute of Siddha, Tambaram Sanatorium, Chennai

Chennai
TAMIL NADU
600047
India 
Phone  9025575185  
Fax    
Email  drlakshmiramaswamy@gmail.com  
 
Source of Monetary or Material Support  
National Institute of Siddha, Tambaram Sanatorium, Chennai-47 
 
Primary Sponsor  
Name  National Institute of Siddha 
Address  Room no 7/8, Department of Maruthuvam, National Institute of Siddha, Tambaram Sanatorium, Chennai-47 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr NISHA K J  Ayothidoss Pandithar Hospital  Room no 7/8, Department of Maruthuvam, National Institute of Siddha, Tambaram Sanatorium, Chennai-47
Chennai
TAMIL NADU 
9965360794

nishajageerushan@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K802||Calculus of gallbladder without cholecystitis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  NIL  NIL 
Intervention  Vengara parpam, Bavana panjangula thailam, Santha santhrothayam, Manjal noi kudineer  Vengara Parpam - 100 mg Bd With Ghee, Bavana Panjangula Thailam - 4 ml Bd With Milk, Santha Santhrothayam - 2 Bd With Honey, Manjal noi kudineer - 5grams Bd made into Decoction. For 90 Days  
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1.Participants who were diagnosed Cholelithiasis by ultrasound scanning – size of the gallbladder stone between 3 to 10 mm. 
 
ExclusionCriteria 
Details  1.Participants with comorbidities like renal failure and liver cirrhosis
2.Pregnant and lactating mother.
3.Severe Cholecystitis, Choledocholithiasis, Acute and Chronic Pancreatitis.
4.Participants with Gallstone present in neck of gall bladder.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Reduction in the size of stone will be assessed by ultra sonogram before and after treatment  6 MONTHS 
 
Secondary Outcome  
Outcome  TimePoints 
Scoring Difference will be assessed in OTAGO Gallstones condition specific questionnaire in cholelithiasis participants before and after taking siddha treatment  6 MONTHS 
 
Target Sample Size   Total Sample Size="20"
Sample Size from India="20" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   23/06/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   BACKGROUND: Siddha medicine is an ancient systems of medicine which contributes in treating the disease as well as plays an important role in revitalizing and rejuvenating the mind and body. Generally 4448 types of diseases are classified in the siddha system. This classification is mainly based on the derangement of 3 major humors, Vatham, Pitham and Kabam. Gall bladder (Pitha pai) is an organ which is existing in Pithasthanam in our body. Gallstone disease is caused by derangement of Pitham humor. Gallstones are formed from the constituents of the bile (cholesterol, bile pigments and calcium salts) along with other organic components. They are usually formed in gallbladder, but sometimes develop within extrahepatic biliary passages, and rarely in the larger intrahepatic bile duct. In India, the prevalence of gall stones is about 10-15% in adults[2]. The incidence of gall stones varies markedly in different geographic areas, age, gender, diet and various other risk factors. Gallstones are common in 4Fs acronym for – Fat, Female, Fertile(multipara) and Forty. Gallstone in one among the lifestyle related diseases caused by the recent change in the dietary pattern. There is an increased number of patients affected by Cholelithiasis, reporting at the OPD. This trial may provide alternate option for participants since surgery is the most suggested intervention in modern medicine. Most of the trial drug contains Hepatoprotective, hypolipidemic, antioxidant, Lithotriptic activity as mentioned in various research articles. Hence I had chosen this formulation “Vengara parpam, Bavana panjangula thailam, Santha Santhrothayam, Manjal noi kudineer” for the management of Cholelithiasis.

OBJECTIVE: To evaluate the therapeutic effectiveness of selective Siddha medicines - Vengara parpam, Bavana panjangula thailam, Santha Santhrothayam, Manjal noi kudineer in the management of Cholelithiasis by reduction in size of the stone will be measured.

METHODOLOGY: 20 diagnosed patients of Cholelithiasis within the age limit of 20-60 years willing to paticipate in the study by signing the consent form will be enrolled in the study based on the inclusion criteria and exclusion criteria.

OUTCOME: Reduction in size of stone will be assessed by using ultrasonogram before and after taking siddha treatment. Scoring Difference will be assessed in OTAGO Gallstones condition specific questionnaire in the cholelithiasis participants before and after taking siddha treatment.

RESULTS AND DISCUSSION: The results will be statistically analysed and reported.

KEYWORDS: Cholelithiasis, Pithapai kal, Vengara parpam, Bavana panjangula thailam, Santha Santhrothayam, Manjal noi kudineer.
 
Close